生物样本采集试剂盒市场（按样本类型、最终用户、产品类型和应用划分）－2025-2032年全球预测

预计到 2032 年，生物样本采集试剂盒市场规模将达到 183.6 亿美元，复合年增长率为 8.85%。

为决策者提供关于塑造生物样本采集试剂盒生态系统的新临床和操作技术要务的全面报告

生物样本采集生态系处于临床照护、生命科学研究和分散式医疗服务交会点，要求各利益相关者在科学严谨性和操作实用性之间取得平衡。检测灵敏度的提高、以患者为中心的检测模式以及自动化程度的提高，都在推动着采集设备的技术需求，同时也提高了用户体验、监管链完整性和运输途中样本稳定性方面的期望。因此，製造商、检查室管理人员和采购团队在评估采集解决方案时，不仅要考虑其与下游工作流程的兼容性，还要考虑其降低分析前变异性和操作摩擦的能力。

变革性趋势正在重塑试剂盒设计、分散式检查、供应链韧性以及监管预期，这要求各相关人员进行策略调整。

生物样本采集试剂盒领域正经历变革性的转变，这主要受技术创新、医疗服务模式转变以及监管要求日益严格的推动。首先，检测灵敏度的提高和分子诊断技术的广泛应用，对样本保存和完整性提出了更高的技术要求，迫使製造商加强对试剂稳定性、容器材料改进以及运输耐受性设计的投入。这些创新使得分散式检查得以更广泛地进行，同时又能确保高复杂度检测的分析可靠性。

2025年美国关税调整的累积影响：供应链韧性、到岸成本、海关复杂性以及价值链中的策略性製造重组

2025年推出调整的关税及贸易政策变化正从多个面向影响生物样本采集试剂盒的价值链，进而影响采购选择、到岸成本和策略性生产决策。某些医疗设备类别进口关税的提高或重新分类，迫使先前依赖成本效益高的跨境采购模式的製造商重新评估供应商合约和总到岸成本。为此，各组织正在加快寻找替代供应商、重新定价商业合同，并在某些情况下扩大本国或週边地区的产能，以提高可预测性并降低受贸易政策波动的影响。

以细分市场为导向的洞察：解释样本类型、不同终端使用者、不同产品类型和各种应用情境的细微差别如何导致差异化的产品策略和商业化方案。

了解生物样本采集试剂盒市场的细分情况对于确定产品优先顺序、优化市场推广策略以及集中研发投资至关重要。根据样本类型，该市场可分为血液、唾液、粪便、组织和尿液。血液可细分为血浆、血清和全血，而组织则分为福马林固定石蜡包埋（FFPE）组织、新鲜组织和冷冻组织。这些区分至关重要，因为不同类型的样本所需的保存化学方法、容器设计和下游处理要求差异显着。因此，製造商分别针对核酸、蛋白质和活细胞开发了专用的底物和稳定化方法。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

• 透过将智慧型手机条码管理和即时追踪功能整合到样本采集包中，加强储存管理
• 偏远地区照护现场诊断应用对非侵入式唾液和呼吸采样试剂盒的需求日益增长
• 开发常温试剂和运输介质简化了全球样品物流，并减少了对低温运输的依赖。
• 利用模组化微流体平台在采集点进行多重生物标记分离与稳定化，此平台适用于采集试剂盒
• 在出货前的预分析过程中，利用人工智慧演算法进行品管，以检测样品污染或不足情况。
• 扩大家用DIY基因检测套组，简化使用者介面并整合电子商务补充装选项

第六章美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

8. 生物样本采集试剂盒市场（依样本类型划分）

• 血
  • 电浆
  • 血清
  • 全血
• 唾液
• 航班
• 组织
  • FFPE组织
  • 新鲜纸巾
  • 冷冻组织
• 尿

9. 依最终用户分類的生物样本采集试剂盒市场

• 生物製药公司
• 诊断实验室
• 居家医疗
• 医院
• 研究所

第十章 生物样本采集试剂盒市场（按产品类型划分）

• 自动化系统
• 多样本试剂盒
• 免洗套装

第十一章 生物样本采集试剂盒市场（按应用领域划分）

• 临床诊断
• 药物发现
• 环境监测
• 基因检测
• 传染病检查

第十二章 生物样本采集试剂盒市场（按地区划分）

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十三章 生物样本采集试剂盒市场（按类别划分）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十四章 各国生物检体采集试剂盒市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十五章 竞争格局

• 2024年市占率分析
• FPNV定位矩阵，2024
• 竞争分析
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Becton Dickinson and Company
  • Abbott Laboratories
  • F. Hoffmann-La Roche AG
  • bioMerieux SA
  • Qiagen NV
  • Greiner Bio-One International GmbH
  • Copan Diagnostics Inc.
  • PerkinElmer, Inc.

The Biological Sample Collection Kits Market is projected to grow by USD 18.36 billion at a CAGR of 8.85% by 2032.

Comprehensive introduction framing the emerging clinical, operational, and technological imperatives that are shaping the biological sample collection kits ecosystem for decision makers

The biological sample collection kits ecosystem sits at the intersection of clinical care, life sciences research, and decentralized health delivery, requiring stakeholders to reconcile scientific rigor with operational practicality. Advances in assay sensitivity, patient-centric testing models, and automation have increased the technical demands placed on collection devices while simultaneously raising expectations for user experience, chain-of-custody integrity, and sample stability during transport. As a result, manufacturers, laboratory directors, and procurement teams must evaluate collection solutions not only for compatibility with downstream workflows but also for their ability to reduce pre-analytical variability and operational friction.

Operational imperatives now include supply reliability, regulatory compliance across jurisdictions, and demonstrable quality systems that support traceability from collection through analysis. These imperatives are complemented by technology trends such as integrated barcoding, ambient-stable preservatives, and modular kit designs that support both centralized and decentralized testing models. As stakeholders navigate this evolving environment, they must balance the need for flexible kit formats with stringent biosafety and data integrity requirements.

This introduction frames the strategic questions that industry leaders face: how to prioritize investments in product development, where to focus partnerships and distribution efforts, and which operational changes will deliver measurable improvements in sample quality and throughput. By understanding these priorities, decision-makers can better align their product roadmaps, procurement strategies, and regulatory engagement to meet the twin goals of scientific fidelity and scalable delivery.

Transformational trends reshaping kit design, decentralised testing, supply chain resilience, and regulatory expectations that demand strategic realignment across stakeholders

The landscape for biological sample collection kits is undergoing transformative shifts driven by technological innovation, changing care delivery models, and heightened regulatory expectations. First, advances in assay sensitivity and the proliferation of molecular diagnostics have elevated the technical requirements for sample preservation and integrity, prompting manufacturers to invest in stabilizing reagents, improved container materials, and transport-robust designs. These innovations are enabling a broader range of decentralized testing while maintaining analytical confidence for high-complexity assays.

Second, patient centricity is reshaping product form factors and user instructions. Remote sample collection and home-based diagnostics are increasing demand for intuitive kit interfaces, simplified instructions for self-collection, and integrated digital support such as mobile-guided workflows and real-time tracking. This trend is causing cross-functional coordination between human factors engineering, regulatory affairs, and digital product teams to ensure both usability and compliance.

Third, supply chain resilience has become a strategic priority as stakeholders reassess single-supplier dependencies, packaging constraints, and temperature-controlled logistics. Companies are responding by diversifying supplier bases, qualifying alternative materials, and investing in regional manufacturing capabilities. Lastly, regulatory scrutiny has intensified around traceability, labeling, and biosafety, encouraging vendors to strengthen quality systems and documentation to expedite approvals and sustain market access. Collectively, these shifts are accelerating the convergence of digital, material science, and operational capabilities within the collection kit sector.

Cumulative effects of 2025 United States tariff adjustments on supply chain resilience, landed costs, customs complexity, and strategic manufacturing redesign across the value chain

Policy changes in tariff schedules and trade measures introduced or adjusted in 2025 have created a multi-dimensional impact on the biological sample collection kits value chain, influencing sourcing choices, landed costs, and strategic manufacturing decisions. When import duties are raised or reclassified for specific medical device categories, manufacturers that previously relied on a cost-efficient cross-border procurement model face immediate pressure to re-evaluate supplier contracts and total landed cost calculations. In response, organizations have accelerated qualification of alternate suppliers, re-priced commercial agreements, and in some cases advanced onshore or nearshore capacity to improve predictability and reduce exposure to trade policy volatility.

Beyond direct cost implications, tariff changes often ripple into logistics and compliance workloads. Increased customs scrutiny requires more granular classification of kit components, more extensive documentation, and tighter coordination with customs brokers and freight forwarders. These administrative burdens can lengthen lead times and create inventory planning challenges, particularly for kits that include temperature-sensitive reagents or specialized consumables. As a consequence, procurement teams are prioritizing suppliers that demonstrate robust customs compliance capabilities and the operational agility to buffer short-term disruptions.

Strategically, tariff-induced pressures are accelerating broader supply chain redesigns. Some organizations are evaluating localized manufacturing to preserve margin and reduce risk, while others are leveraging bonded warehousing, tariff engineering strategies, and trade agreements to mitigate incremental costs. Finally, policy shifts in 2025 have prompted greater emphasis on contractual flexibility, scenario planning, and cross-functional playbooks that align procurement, legal, quality, and commercial teams to respond quickly to evolving trade environments. These measures collectively aim to preserve continuity of supply and protect product affordability without compromising sample integrity or regulatory compliance.

Segmentation-oriented insights explaining how sample type nuances, diverse end users, distinct product types, and varied applications drive differentiated product strategies and commercialization choices

Understanding segmentation is essential to identify product priorities, tailor go-to-market approaches, and focus R&D investments across the biological sample collection kits space. Based on sample type, the market encompasses Blood, Saliva, Stool, Tissue, and Urine; Blood itself is further delineated into Plasma, Serum, and Whole Blood, and Tissue is subdivided into FFPE tissue, Fresh tissue, and Frozen tissue. These distinctions matter because preservation chemistry, container design, and downstream processing requirements vary significantly by specimen type, leading manufacturers to develop specialized substrates and stabilization approaches for nucleic acids, proteins, and viable cells.

Based on end user, the market serves Biopharma companies, Diagnostic laboratories, Home healthcare, Hospitals, and Research institutes. Each end user segment imposes distinct performance, regulatory, and supply requirements: clinical diagnostic laboratories prioritize standardized chain-of-custody and compatibility with automated extraction platforms; biopharma customers emphasize lot consistency and documentation to support clinical trials; home healthcare and patient-directed models demand user-friendly instructions and strong preservative performance at ambient temperatures; hospitals require integration with clinical workflows and hospital supply systems; and research institutes seek flexibility and cost-effective bulk formats for exploratory studies.

Based on product type, the market offers Automated systems, Multi sample kits, and Single use kits. Automated systems integrate with laboratory instrumentation to improve throughput and reduce hands-on time, while multi sample kits enable batch processing and cost efficiencies for high-volume settings. Single use kits are often optimized for point-of-care or single-visit patient sampling where contamination control and ease of disposal are priorities. Finally, based on application, use cases include Clinical diagnostics, Drug discovery, Environmental monitoring, Genetic testing, and Infectious disease testing, each of which imposes distinct analytical sensitivity, preservation, and chain-of-custody expectations. These cross-segment variances shape innovation roadmaps, commercial targeting, and regulatory strategies for manufacturers and buyers alike.

Regional strategic perspectives emphasizing how regulatory regimes, logistics realities, and clinical adoption patterns differ across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics influence nearly every strategic decision for manufacturers and distributors of biological sample collection kits. In the Americas, demand drivers include consolidated clinical laboratory networks, advanced home testing adoption, and a focus on fast-cycle clinical trials that require robust cold-chain logistics and high regulatory standards. North American procurement practices emphasize supplier validation, extended documentation, and integration with large laboratory information systems, encouraging suppliers to demonstrate interoperability and enterprise-grade quality controls.

In Europe, Middle East & Africa, regulatory harmonization efforts coexist with heterogeneous national requirements, which creates both opportunities and complexity for market entry. Manufacturers operating in this region must balance pan-regional strategies with localized compliance and distribution models. The regulatory emphasis on traceability and patient data privacy has prompted investments in secure digital tracking and localized quality documentation, while diverse infrastructure conditions across countries mean that ambient-stable solutions can offer competitive advantages in certain markets.

In Asia-Pacific, rapid expansion of diagnostics capacity and the growth of decentralized testing models are driving demand for adaptable kit formats and scalable manufacturing. Competitive pressure and cost sensitivity in several markets encourage local partnerships and contract manufacturing arrangements. Logistics networks and regulatory frameworks are evolving quickly, requiring agile market access strategies and a nuanced understanding of country-level regulatory authorities. Across all three regions, the interplay of regulatory requirements, distribution infrastructure, and clinical adoption rates determines which product attributes will resonate most strongly with buyers.

Key competitive patterns and company-level strategies showing how platform approaches, strategic partnerships, regulatory readiness, and targeted M&A are shaping industry positioning and differentiation

Competitive dynamics in the biological sample collection kits sector are defined by a mix of technology differentiation, quality systems maturity, and commercial scale. Leading organizations invest in platform approaches that allow modular adaptation across sample types and applications, enabling them to support clinical diagnostics, research studies, and decentralized testing with common core components. This platform mentality reduces time to market for new kit variants while allowing for economies in procurement and manufacturing.

Partnerships and vertical integration are emerging as common strategic responses to market complexity. Companies are forming alliances with logistics providers, reagent suppliers, and digital solution vendors to offer end-to-end sample-to-lab workflows that reduce friction for end users. At the same time, strategic acquisitions focused on niche capabilities-such as ambient-stability chemistries or advanced barcoding systems-are being used to fill portfolio gaps and accelerate product differentiation.

Quality and regulatory readiness remain market entry barriers that sustain advantage for established firms with audited manufacturing sites, ISO certifications, and comprehensive documentation practices. New entrants often focus on a narrow application or user segment to prove performance before broadening their commercial footprint. Finally, commercial approaches are bifurcating between enterprise sales models that emphasize laboratory integration and smaller, nimble go-to-market teams that focus on home healthcare and direct-to-consumer channels, each requiring distinct sales, training, and post-sales support capabilities.

Actionable strategic steps for leaders to fortify supply chains, integrate patient-centric design, streamline regulatory readiness, and calibrate commercial models for sustained advantage

Industry leaders should pursue a coordinated set of actions to strengthen resilience, differentiate products, and accelerate go-to-market impact. First, integrate human factors and digital support into product design to enhance self-collection success rates and reduce pre-analytical error; incorporating mobile-guided workflows and clear visual instructions can materially improve sample quality and user confidence. Second, prioritize qualification of diverse suppliers and nearshoring options to reduce exposure to tariff-driven cost volatility and logistics bottlenecks, while maintaining rigorous incoming inspection and supplier scorecarding practices to ensure consistency.

Third, invest in regulatory and quality infrastructure that supports rapid evidence generation and cross-jurisdictional approvals; standardized documentation templates and robust lot release testing can shorten approval timelines and improve buyer confidence. Fourth, align commercialization models with end user needs by offering integrated solutions for large laboratory systems and simplified, consumer-oriented kits for home healthcare channels, ensuring that training, technical support, and returns policies are optimized for each segment. Fifth, deploy scenario-planning and contractual flexibility to respond to policy changes, including options for bonded warehousing, tariff classification review, and contingent sourcing contracts that can be activated if trade conditions change.

Finally, establish a cross-functional commercialization playbook that links R&D, regulatory, supply chain, and commercial teams to speed decision-making and close the loop between field feedback and product iterations. These steps collectively will help organizations preserve product quality, protect margin, and capture emerging opportunities in a rapidly evolving landscape.

Robust mixed-methods research approach detailing expert interviews, documentary review, triangulation techniques, and validation safeguards used to ensure analytical rigor and reliability

The study's findings are grounded in a multi-method research framework that combines primary qualitative inputs with rigorous secondary sources and validation processes. Primary research included structured interviews with subject matter experts across manufacturing, laboratory operations, procurement, and regulatory affairs, enabling the capture of operational nuances and firsthand perspectives on product performance and commercial dynamics. These interviews informed hypothesis development and were used to probe real-world constraints such as cold-chain logistics, sample stability concerns, and user experience barriers.

Secondary research entailed systematic review of peer-reviewed literature, regulatory guidance documents, and public filings to contextualize technological trends, quality standards, and policy shifts. Data triangulation methods were applied to reconcile insights from different sources and to surface consistent themes across evidence streams. Throughout the process, quality controls included validation checks with independent experts, cross-referencing of technical claims against regulatory documentation, and iterative refinement of findings to remove ambiguities.

The methodology emphasizes transparency in assumptions, reproducibility of analytic steps, and traceability of qualitative inputs. Where applicable, sensitivity analyses and scenario-based assessments were used to explore the operational implications of supply chain disruptions and policy shifts, with results framed as strategic considerations rather than numerical projections. This approach ensures that the report's conclusions are actionable, defensible, and grounded in a combination of practitioner insight and documentary evidence.

Concise synthesis of core findings emphasizing the interplay of innovation, operational resilience, segmentation strategy, and regional differentiation that determines competitive success

The conclusion synthesizes the study's central themes: product innovation is being driven by analytical requirements and patient-centric delivery models; supply chain resilience and regulatory readiness are now core strategic priorities; segmentation nuances materially affect product design and commercialization choices; and regional dynamics require tailored market access and distribution approaches. Taken together, these threads point to a market environment where technical differentiation and operational excellence are both critical to long-term success.

Organizations that successfully align design, manufacturing, and commercial processes will be better positioned to withstand policy shifts and logistics disruptions while capturing opportunities in decentralized testing and specialized clinical applications. Conversely, firms that neglect supplier diversification, human factors, and regulatory robustness risk diminished product performance and slower market adoption. The balance of these risks and opportunities suggests that cross-functional agility, thoughtful segmentation strategies, and deliberate regional playbooks will be the primary determinants of competitive advantage.

In closing, stakeholders should treat the insights in this study as a strategic roadmap for aligning investments, partnerships, and operational practices with the evolving needs of laboratories, clinicians, and end users. By focusing on quality, usability, and resilient supply chains, organizations can both protect existing revenue streams and create pathways to new service models and clinical applications.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Integration of smartphone-enabled barcoding and real-time tracking in sample collection kits to enhance chain of custody
• 5.2. Rising demand for noninvasive saliva and breath sampling kits in point-of-care diagnostic applications in remote settings
• 5.3. Development of ambient temperature stable reagents and transport media to simplify global sample logistics and reduce cold chain reliance
• 5.4. Adoption of modular microfluidic platforms in collection kits for multiplexed biomarker separation and stabilization at source
• 5.5. Use of artificial intelligence algorithms in pre-analytical quality control to detect sample contamination or insufficient volume before shipping
• 5.6. Expansion of DIY at-home genetic testing kits with simplified user interfaces and integrated e-commerce replenishment options

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biological Sample Collection Kits Market, by Sample Type

• 8.1. Blood
  • 8.1.1. Plasma
  • 8.1.2. Serum
  • 8.1.3. Whole Blood
• 8.2. Saliva
• 8.3. Stool
• 8.4. Tissue
  • 8.4.1. FFPE Tissue
  • 8.4.2. Fresh Tissue
  • 8.4.3. Frozen Tissue
• 8.5. Urine

9. Biological Sample Collection Kits Market, by End User

• 9.1. Biopharma Companies
• 9.2. Diagnostic Laboratories
• 9.3. Home Healthcare
• 9.4. Hospitals
• 9.5. Research Institutes

10. Biological Sample Collection Kits Market, by Product Type

• 10.1. Automated Systems
• 10.2. Multi Sample Kits
• 10.3. Single Use Kits

11. Biological Sample Collection Kits Market, by Application

• 11.1. Clinical Diagnostics
• 11.2. Drug Discovery
• 11.3. Environmental Monitoring
• 11.4. Genetic Testing
• 11.5. Infectious Disease Testing

12. Biological Sample Collection Kits Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Biological Sample Collection Kits Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Biological Sample Collection Kits Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Analysis
  • 15.3.1. Thermo Fisher Scientific Inc.
  • 15.3.2. Danaher Corporation
  • 15.3.3. Becton Dickinson and Company
  • 15.3.4. Abbott Laboratories
  • 15.3.5. F. Hoffmann-La Roche AG
  • 15.3.6. bioMerieux SA
  • 15.3.7. Qiagen N.V.
  • 15.3.8. Greiner Bio-One International GmbH
  • 15.3.9. Copan Diagnostics Inc.
  • 15.3.10. PerkinElmer, Inc.

LIST OF FIGURES

• FIGURE 1. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 11. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. GCC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. EUROPEAN UNION BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. BRICS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. G7 BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. NATO BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. BIOLOGICAL SAMPLE COLLECTION KITS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 28. BIOLOGICAL SAMPLE COLLECTION KITS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. BIOLOGICAL SAMPLE COLLECTION KITS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, BY REGION, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PLASMA, BY REGION, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PLASMA, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PLASMA, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PLASMA, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SERUM, BY REGION, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SERUM, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SERUM, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SERUM, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SERUM, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SALIVA, BY REGION, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SALIVA, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SALIVA, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SALIVA, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY STOOL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY STOOL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY STOOL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY STOOL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY STOOL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY STOOL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FFPE TISSUE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FFPE TISSUE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FFPE TISSUE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FFPE TISSUE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FFPE TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FFPE TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FRESH TISSUE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FRESH TISSUE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FRESH TISSUE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FRESH TISSUE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FRESH TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FRESH TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FROZEN TISSUE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FROZEN TISSUE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FROZEN TISSUE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FROZEN TISSUE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FROZEN TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY FROZEN TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY URINE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY URINE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY URINE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY URINE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY URINE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BIOPHARMA COMPANIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BIOPHARMA COMPANIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BIOPHARMA COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BIOPHARMA COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BIOPHARMA COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BIOPHARMA COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY MULTI SAMPLE KITS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY MULTI SAMPLE KITS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY MULTI SAMPLE KITS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY MULTI SAMPLE KITS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY MULTI SAMPLE KITS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY MULTI SAMPLE KITS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SINGLE USE KITS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SINGLE USE KITS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SINGLE USE KITS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SINGLE USE KITS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SINGLE USE KITS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SINGLE USE KITS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 149. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 150. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 151. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 152. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 153. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 154. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 155. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 156. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 157. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 158. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 159. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 160. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 161. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 162. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 163. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 164. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 165. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 166. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 167. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
• TABLE 168. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2025-2032 (USD MILLION)
• TABLE 169. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 170. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 171. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 172. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 173. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 174. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 175. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 176. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 177. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 178. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 179. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 180. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 181. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
• TABLE 182. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2025-2032 (USD MILLION)
• TABLE 183. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 184. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 185. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 186. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 187. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 188. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 189. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 190. NORTH AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 191. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 192. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 193. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 194. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 195. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
• TABLE 196. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2025-2032 (USD MILLION)
• TABLE 197. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 198. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 199. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 200. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 201. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 202. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 203. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 204. LATIN AMERICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 205. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 206. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 207. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 208. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 209. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
• TABLE 210. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2025-2032 (USD MILLION)
• TABLE 211. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 212. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 213. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 214. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 215. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 216. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 217. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 218. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 219. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 220. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 221. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 222. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 223. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
• TABLE 224. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2025-2032 (USD MILLION)
• TABLE 225. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 226. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 227. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 228. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 229. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 230. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 231. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 232. EUROPE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 233. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 234. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 235. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 236. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 237. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
• TABLE 238. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2025-2032 (USD MILLION)
• TABLE 239. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 240. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 241. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 242. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 243. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 244. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 245. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 246. MIDDLE EAST BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 247. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 248. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 249. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 250. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 251. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
• TABLE 252. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2025-2032 (USD MILLION)
• TABLE 253. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 254. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 255. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 256. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 257. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 258. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 259. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 260. AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 261. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 262. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 263. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 264. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 265. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
• TABLE 266. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2025-2032 (USD MILLION)
• TABLE 267. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 268. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 269. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 270. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 271. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 272. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 273. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 274. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 275. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 276. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 277. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 278. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 279. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 280. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 281. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
• TABLE 282. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, 2025-2032 (USD MILLION)
• TABLE 283. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 284. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 285. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 286. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 287. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 288. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 289. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 290. ASEAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 291. GCC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 292. GCC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 293. GCC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)